Redbud Labs, Inc.
Chapel Hill, NC · CIK 0001705921 · Medtech · Private
Automated genomic library preparation platform for viral sequencing with modular, combinable operations (end repair, barcoding, adapter ligation) deployable in resource-limited settings
redbudlabs.com →- Grants
- $29M
- 35 awards
- Sector median: 1
- Raised
- $520K
- 2 Form D · Dec 2018
- 94 months since last filing
- Contracts
- $1.8M
- 1 award · Health and Human S
- #236 of 4531 in medtech
- Patents
- 40
- 8 granted · 32 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · HLS-Rugged point-of-care device for global hemostasis testing of whole blood | $197,455 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Microfilm to enable enhanced mixing in low-resource diagnostics | $146,034 | |
| Federal grant | Department of Health and Human Services · Phase I · Device for rapid extraction of rare pathogens from raw samples | $297,090 | |
| Federal grant | Department of Health and Human Services · Phase II · HLS-Rugged point-of-care device for global hemostasis testing of whole blood | $1,089,446 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: Microfilm to enable enhanced mixing in low-resource diagnostics | $1,323,749 | |
| Private capital raised | Form D · SEC | $215,000 | |
| Federal grant | Department of Health and Human Services · Phase II · HLS-Rugged point-of-care device for global hemostasis testing of whole blood | $391,868 | |
| Federal grant | Department of Health and Human Services · Phase I · Microarray performance enhancement using microfluidic mixing | $298,963 | |
| Federal grant | Department of Health and Human Services · Phase II · Device for rapid extraction of rare pathogens from raw samples | $2,135,785 | |
| Federal grant | Department of Health and Human Services · Phase I · Device for rapid, on-chip, sample-to-answer bacterial identification and drug susceptibility testing | $294,357 | |
| Private capital raised | Form D · SEC | $304,995 | |
| Federal grant | Department of Health and Human Services · Phase II · Device for rapid extraction of rare pathogens from raw samples | $994,953 | |
| Federal grant | Department of Health and Human Services · Phase I · Microplate bioreactor for high throughput biopharmaceutical process development | $297,446 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Point-of-care HIV viral load system using RPA and MXR | $298,450 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · System for faster microarray assays and end-to-end workflow automation | $1,986,975 | |
| Federal grant | Department of Health and Human Services · Phase II · System for faster microarray assays and end-to-end workflow automation | $987,240 | |
| Federal grant | Department of Health and Human Services · Phase II · A modular platform for infectious disease surveillance at point-of-need. | $299,268 | |
| Federal grant | Department of Health and Human Services · Phase I · Enhanced MDx: a computational model to optimize pre-analytical pathogen isolation from whole blood. | $296,954 | |
| Federal grant | Department of Health and Human Services · Phase II · A modular platform for infectious disease surveillance at point-of-need. | $291,649 | |
| Federal grant | Department of Health and Human Services · Phase I · Rapid point-of-care molecular test for HCV VL | $288,729 | |
| Federal grant | Department of Health and Human Services · Phase I · System for unitary automation of library preparation | $292,788 | |
| Federal grant | Department of Health and Human Services · Phase I · MEMS-enhanced solid-phase isothermal amplification for rapid, multiplexed molecular diagnostics | $304,329 | |
| Federal grant | Department of Health and Human Services · Phase II · Enhanced MDx: a computational model to optimize pre-analytical pathogen isolation from whole blood | $1,986,695 | |
| Federal grant | Department of Health and Human Services · Phase II · Point-of-care HIV viral load system using RPA and MXR | $1,902,994 | |
| Federal grant | Department of Health and Human Services · Phase II · A modular platform for infectious disease surveillance at point-of-need. | $1,982,637 | |
| Federal grant | Department of Health and Human Services · Phase I · Improving extraction success of FFPE samples with automated and reliable microfluidic sample preparation | $279,013 | |
| Federal grant | Department of Health and Human Services · Phase II · Point-of-care HIV viral load system using RPA and MXR | $950,372 | |
| Federal grant | Department of Health and Human Services · Phase II · Enhanced MDx: a computational model to optimize pre-analytical pathogen isolation from whole blood | $987,019 | |
| Federal grant | Department of Health and Human Services · Phase II · A modular platform for infectious disease surveillance at point-of-need. | $983,642 | |
| Federal contract | Department of Health and Human Services · Implement Extraction Compatibility With Whole Blood And Tissue Lysates With Industry Acceptable Biosafety Standards That Include Sterilization And Produce An Instrument Designed With Portability And Rapid Installation In Low Resource Environments. Th | $1,799,353 | |
| Federal grant | Department of Health and Human Services · Phase II · Rapid point-of-care molecular test for HCV VL | $999,310 | |
| Federal grant | Department of Health and Human Services · Phase II · System for unitary automation of library preparation | $1,223,863 | |
| Federal grant | Department of Health and Human Services · Phase II · Improving extraction success of FFPE samples with automated and reliable microfluidic sample preparation | $1,238,908 | |
| Federal grant | Department of Health and Human Services · Phase II · Rapid point-of-care molecular test for HCV VL | $996,914 | |
| Federal grant | Department of Health and Human Services · Phase II · System for unitary automation of library preparation | $1,235,487 | |
| Federal grant | Department of Health and Human Services · Phase II · Improving extraction success of FFPE samples with automated and reliable microfluidic sample preparation | $1,261,092 | |
| Federal grant | Department of Health and Human Services · Phase II · Improving extraction success of FFPE samples with automated and reliable microfluidic sample preparation | $50,000 | |
| Federal grant | Department of Health and Human Services · Phase II · System for unitary automation of library preparation | $48,000 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 233 | Natera | $1.9M | — |
| 234 | ACCELERATED MEDICAL DIAGNOSTICS, INC | $1.9M | — |
| 235 | SYLVATICA BIOTECH INC | $1.8M | — |
| 236 | Redbud Labs, Inc. | $1.8M | $520K |
| 237 | Particle Metrix | $1.8M | — |
| 238 | ROSELLINI SCIENTIFIC, LLC | $1.8M | — |
| 239 | HELIOWAVE TECHNOLOGIES LLC | $1.7M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Richard SperoDirector · Executive Officer
- Richard SuperfineDirector
- Kenneth WestDirector · Executive Officer
Patents
- Magnetic-based Actuation Mechanisms For And Methods Of Actuating Magnetically Responsive Microposts In A Reaction Chamberapplication
- Microscale Bioreactor System For And Method Of Providing Cell Culture Growth Conditions In A Small-volume Vesselgranted
- System And Methods Of Using Microfluidic Agitation To Enhance Multiplexed Solid-phase Isothermal Nucleic Acid Amplificationapplication
- Magnetic-based Actuation Mechanisms For Actuating Magnetically-responsive Microposts In A Reaction Chambergranted
- System And Methods Of Using Microfluidic Agitation To Enhance Multiplexed Solid-phase Isothermal Nucleic Acid Amplificationgranted
- Magnetic-based Actuation Mechanisms For And Methods Of Actuating Magnetically Responsive Microposts In A Reaction Chambergranted
- Modular Microvalves For Microfluidic Devices And Methods Of Using The Sameapplication
- Sample Tube Connectors And Methods For Attaching A Microfluidics Device To A Sample Tubeapplication
- Modular Active Surface Devices for Microfluidic Systems and Methods of Making Samegranted
- Microfluidic Devices and Methods Including Flexible Membranesapplication
- Microscale Bioreactor System For And Method Of Providing Cell Culture Growth Conditions In A Small-volume Vesselapplication
- Modular Active Surface Devices for Microfluidic Systems and Methods of Making Same Including Adhesive-Free Assemblyapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.